S100A11 (calgizzarin) is released by circulating mononuclear cells and its elevated plasma levels distinguish systemic lupus erythematosus patients from healthy individuals.

Lucie Andrés Cerezo^a, Barbora Šumová^{b c}, Hana Hulejová^a, Hana Štorkánová^{b c}, Lenka Szczuková^{d e}, Michal Tomčík^{b c}, Radim Bečvář^{b c}, Karel Pavelká^{b c}, Jiří Vencovský^{b c}, Jakub Závada^{b c}, Ladislav Šenolt^f

1. ^aInstitute of Rheumatology, Prague, Czech Republic
2. ^bInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
3. ^cInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, #N#Czech Republic
4. ^dInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
5. ^eInstitute of Biostatistics and Analyses, Faculty of Medicine Masaryk University Brno Czech Republic
6. ^fInstitute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic. senolt@revma.cz